NCT02213484View on ClinicalTrials.gov

Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

July 1, 2016

Study Completion Date

July 1, 2016

Conditions
Marfan SyndromeLoeys-Dietz SyndromeThoracic Aortic Aneurysm and Dissection SyndromesEhlers-Danlos Type IV SyndromeTurner Syndrome
Trial Locations (2)

80045

Children's Hospital Colorado, Aurora

University of Colorado Hospital, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02213484 - Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes | Biotech Hunter | Biotech Hunter